Observation of hard scattering in photoproduction events with a large rapidity gap at HERA

Events with a large rapidity gap and total transverse energy greater than 5 GeV have been observed in quasi-real photoproduction at HERA with the ZEUS detector. The distribution of these events as a function of the $\gamma p$ centre of mass energy is consistent with diffractive scattering. For total transverse energies above 12 GeV, the hadronic final states show predominantly a two-jet structure with each jet having a transverse energy greater than 4 GeV. For the two-jet events, little energy flow is found outside the jets. This observation is consistent with the hard scattering of a quasi-real photon with a colourless object in the proton.Comment: 19 pages, latex, 4 figures appended as uuencoded fil

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Introduction: The distribution of histopathological features of invasive breast tumors in BRCA1 or BRCA2 germline mutation carriers differs from that of individuals with no known mutation. Histopathological features thus have utility for mutation prediction, including statistical modeling to assess pathogenicity of BRCA1 or BRCA2 variants of uncertain clinical significance. We analyzed large pathology datasets accrued by the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and the Breast Cancer Association Consortium (BCAC) to reassess histopathological predictors of BRCA1 and BRCA2 mutation status, and provide robust likelihood ratio (LR) estimates for statistical modeling. Methods: Selection criteria for study/center inclusion were estrogen receptor (ER) status or grade data available for invasive breast cancer diagnosed younger than 70 years. The dataset included 4,477 BRCA1 mutation carriers, 2,565 BRCA2 mutation carriers, and 47,565 BCAC breast cancer cases. Country-stratified estimates of the

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers

Endogenous polypeptide-chain length and partial sequence of aspartate transcarbamoylase from wheat, characterised by immunochemical and cDNA methods

Aspartate transcarbamoylase (ATCase) is purified from wheat germ as a monofunctional trimer of 36 kDa chains. The possibility that this may be a proteolytic fragment of a large endogenous complex in which ATCase is covalently fused to other pyrimidine-pathway enzymes (such as exists in animals or fungi) was tested. Examination of a rabbit antiserum raised against the purified enzyme confirmed the presence of anti-(wheat ATCase) antibodies by several independent methods. Extracts of wheat seedlings prepared under non-proteolysing conditions were challenged by the antiserum, and in some cases by purified anti-(36 kDa ATCase) antibodies, using immunoblotting techniques. The 36 kDa species was the dominant immunopositive polypeptide. However, the extract also contained small amounts of two larger (45 and 55 kDa) immunopositive polypeptides, as well as traces of polypeptides smaller than 36 kDa, which were assumed to be minor proteolytic products. Neither of the 45 or 55 kDa polypeptides is large enough to also incorporate a carbamoyl phosphate synthetase or dihydroorotase of the sizes found in other organisms. They may be targeted precursors of ATCase with intact leader sequences. A screen of a wheat cDNA expression library by the anti-(ATCase) serum yielded a single positive clone which was shown, by DNA sequencing, to be a concatemer of two cDNAs, one of which encoded a partial ATCase. Northern analysis using this clone as probe identified two transcripts of about 1.3 and 1.0 kbp, but showed no evidence of a transcript of 2 kbp or greater which would be required to encode a bifunctional polypeptide. These results confirm that wheat ATCase is not translationally fused to dihydroorotase or carbamoylphosphate synthetase, as it is in animals and fungi. The deduced amino-acid sequence of the partial wheat ATCase is compared with the catalytic chain of the ATCase from Escherichia coli and with other ATCases

Declarative and procedural semantics of fuzzy similarity based unification

summary:In this paper we argue that for fuzzy unification we need a procedural and declarative semantics (as opposed to the two valued case, where declarative semantics is hidden in the requirement that unified terms are syntactically – letter by letter – identical). We present an extension of the syntactic model of unification to allow near matches, defined using a similarity relation. We work in Hájek’s fuzzy logic in narrow sense. We base our semantics on a formal model of fuzzy logic programming extended by fuzzy similarities and axioms of predicate calculus with equality. Rules are many valued implications and not Horn clauses. We prove soundness and completeness of fuzzy similarity based unification